Ironwood Takes in $25M
Cambridge, MA-based Ironwood Pharmaceuticals, which is developing a drug to treat irritable bowel syndrome, has collected $25 million in a new venture financing round, according to regulatory documents posted yesterday. The investors weren’t named in the documents, but Terry McGuire, a partner at Polaris Venture Partners in Waltham, MA, is listed as a board member. In May, Ironwood raised $40 million in upfront payments from Spanish development and commercialization partner Laboratorios Almirall. CEO Peter Hecht did not immediately respond to Xconomy’s request for comment on the funding round; according to Mass High Tech, Ironwood has now raised some $315 million in equity financing overall.